top of page

Clinical Trials & Research Studies in Philadelphia, PA

Tristar Clinical Investigations offers paid research studies to treat specific areas of health, creating new ways to help treat common illnesses and health conditions. From gout and obesity to diabetes and COVID, our team continually practices reliable research methods to provide patients with the highest quality of healthcare, making treatment more effective than ever.

Clinical Trial Process at Tristar Clinical Investigations

Our clinical research facility uses safe and effective testing for investigational medications, helping find the best solutions to various health concerns. Tristar Clinical assesses new treatments, providing leading solutions for common and obscure diseases, epidemics, and medical conditions, improving the existing available options.

We conduct Phase II through IV clinical trials. Phase II through IV clinical trials further evaluate the effectiveness and safety of a drug, the efficacy of a drug compared to other treatments, and the benefits and risks of a drug.

Learn More About Participating in Our Clinical Trials

At Tristar Clinical Investigations, we welcome participants to help us improve medical practices and find the best solutions for various diseases, illnesses, and epidemics. With each clinical trial, we have a specific set of guidelines to find the most suitable subjects to help us in our research studies. Our office uses an in-depth screening process before enrollment, ensuring our data and research are as accurate as possible. We consistently have new research studies and medical trials for you to explore and apply for.

Past Clinical Trials at Tristar Clinical Investigations

Tristar Clinical Investigations has participated in many previous clinical trials over the past 25 years. Our clinical research in Philadelphia has included trials for ailments and diseases like depression, ED, fibromyalgia, hypertension, diabetes and chronic pain, and more. Contact our office today to learn more about our past, present, and upcoming clinical trials in Philadelphia, PA.

bottom of page